Evidence map›Paper›PMID 40618185›Full record

ArticleInfection & chemotherapy2025

Genomic Analysis of Multidrug Resistant

Abiodun Tola Seriki, Chioma Obi, Amusa Azeez Olashile, Utibeima Udo Essiet, Desmond Wemimo Akingboye, Abraham Ajayi, Tenny Obiageli Gladys Egwuatu, Stella Smith

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection & chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Genomic Epidemiology ofChina CDC weekly · 2026
    Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Abiodun Tola SerikiDepartment of Biological Sciences, College of Natural and Applied Sciences, Bells University of Technology, Ota, Ogun State, Nigeria.ORCID https://orcid.org/0000-0001-9406-3691
Chioma ObiDepartment of Biological Sciences, College of Natural and Applied Sciences, Bells University of Technology, Ota, Ogun State, Nigeria.ORCID https://orcid.org/0000-0002-3377-5115
Amusa Azeez OlashileDepartment of Biological Sciences, College of Natural and Applied Sciences, Bells University of Technology, Ota, Ogun State, Nigeria.ORCID https://orcid.org/0009-0007-8777-8577
Utibeima Udo EssietDepartment of Molecular Biology and Biotechnology, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.ORCID https://orcid.org/0000-0003-0422-8689
Desmond Wemimo AkingboyeDepartment of Microbiology, Faculty of Science, University of Lagos, Akoka, Yaba, Nigeria.ORCID https://orcid.org/0009-0009-4260-7728
Abraham AjayiDepartment of Molecular Biology and Biotechnology, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.ORCID https://orcid.org/0000-0001-6681-1795
Tenny Obiageli Gladys EgwuatuDepartment of Microbiology, Faculty of Science, University of Lagos, Akoka, Yaba, Nigeria.ORCID https://orcid.org/0000-0002-4878-5551
Stella SmithDepartment of Molecular Biology and Biotechnology, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.ORCID https://orcid.org/0000-0003-2163-1189

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibiotic resistanceEnterobacter hormaecheiPlasmidSepsisWhole genome sequencing

Identifiers

PMID40618185
PMCPMC12230383

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.